DE60001640D1 - Dreidimensionale struktur enthaltend hyaluronsäurederivat, hergestellt durch die technik von superkritischen antilösungsmitteln - Google Patents

Dreidimensionale struktur enthaltend hyaluronsäurederivat, hergestellt durch die technik von superkritischen antilösungsmitteln

Info

Publication number
DE60001640D1
DE60001640D1 DE60001640T DE60001640T DE60001640D1 DE 60001640 D1 DE60001640 D1 DE 60001640D1 DE 60001640 T DE60001640 T DE 60001640T DE 60001640 T DE60001640 T DE 60001640T DE 60001640 D1 DE60001640 D1 DE 60001640D1
Authority
DE
Germany
Prior art keywords
hyaluronic acid
solvents
produced
technology
dimensional structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60001640T
Other languages
English (en)
Other versions
DE60001640T2 (de
Inventor
Paolo Pallado
Marco Baggio
Carbonare Maurizio Dalle
Lanfranco Callegaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia Farmaceutici SpA
Original Assignee
Fidia Advanced Biopolymers SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Advanced Biopolymers SRL filed Critical Fidia Advanced Biopolymers SRL
Application granted granted Critical
Publication of DE60001640D1 publication Critical patent/DE60001640D1/de
Publication of DE60001640T2 publication Critical patent/DE60001640T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F9/00—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2201/00—Foams characterised by the foaming process
    • C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
    • C08J2201/054—Precipitating the polymer by adding a non-solvent or a different solvent
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2203/00—Foams characterized by the expanding agent
    • C08J2203/08—Supercritical fluid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Textile Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60001640T 1999-04-08 2000-04-06 Dreidimensionale struktur enthaltend hyaluronsäurederivat, hergestellt durch die technik von superkritischen antilösungsmitteln Expired - Lifetime DE60001640T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITPD990071 1999-04-08
IT1999PD000071A IT1306644B1 (it) 1999-04-08 1999-04-08 Strutture tridimensionali comprendenti derivati dell'acido ialuronicoottenibili mediante la tecnica antisolvente supercritico.
PCT/EP2000/003081 WO2000061675A1 (en) 1999-04-08 2000-04-06 Three-dimensional structures containing hyaluronic acid derivatives obtained by the supercritical antisolvent technique

Publications (2)

Publication Number Publication Date
DE60001640D1 true DE60001640D1 (de) 2003-04-17
DE60001640T2 DE60001640T2 (de) 2004-03-25

Family

ID=11392548

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60001640T Expired - Lifetime DE60001640T2 (de) 1999-04-08 2000-04-06 Dreidimensionale struktur enthaltend hyaluronsäurederivat, hergestellt durch die technik von superkritischen antilösungsmitteln

Country Status (10)

Country Link
US (1) US7087745B1 (de)
EP (1) EP1169387B1 (de)
JP (1) JP2002541888A (de)
AT (1) ATE234341T1 (de)
AU (1) AU765563B2 (de)
CA (1) CA2369284C (de)
DE (1) DE60001640T2 (de)
ES (1) ES2194727T3 (de)
IT (1) IT1306644B1 (de)
WO (1) WO2000061675A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20010032A1 (it) 2001-02-09 2002-08-09 Fidia Advanced Biopolymers Srl Innesti ingegnerizzati per la riparazione di difetti osteocondrali
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
AU2003228014B2 (en) * 2003-04-04 2009-11-05 Nobil Bio Ricerche S.R.L. Vascular stent
US8512730B2 (en) * 2004-07-12 2013-08-20 Isto Technologies, Inc. Methods of tissue repair and compositions therefor
AU2005287402B2 (en) * 2004-07-12 2011-03-03 Isto Technologies Ii, Llc Tissue matrix system
EP1973554B1 (de) * 2005-12-07 2015-01-14 Isto Technologies Inc. Verfahren zur reparatur von knorpel
ITPD20060219A1 (it) 2006-05-31 2007-12-01 Fidia Farmaceutici Composizioni farmaceutiche contenenti acido ialuronico solfatato nel trattamento dell'osteoartrosi
KR101594552B1 (ko) 2008-04-04 2016-02-17 유니버시티 오브 유타 리서치 파운데이션 알킬화된 반합성 글리코사미노글리코산 에테르 및 이의 제조 및 사용 방법
ES2829971T3 (es) 2008-09-02 2021-06-02 Tautona Group Lp Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos y usos de los mismos
CA2830933A1 (en) 2011-03-23 2012-09-27 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
US10245306B2 (en) 2012-11-16 2019-04-02 Isto Technologies Ii, Llc Flexible tissue matrix and methods for joint repair
CZ2013913A3 (cs) * 2013-11-21 2015-06-03 Contipro Biotech S.R.O. Objemný nanovlákenný materiál na bázi kyseliny hyaluronové, jejích solí nebo jejich derivátů, způsob jeho přípravy, způsob jeho modifikace, modifikovaný nanovlákenný materiál, nanovlákenný útvar a jejich použití
US10179191B2 (en) 2014-10-09 2019-01-15 Isto Technologies Ii, Llc Flexible tissue matrix and methods for joint repair
CN105734604B (zh) * 2016-03-03 2017-08-25 武汉大学 一种立体复合多糖凝胶及其电化学3d打印制备方法和应用
US11337994B2 (en) 2016-09-15 2022-05-24 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
JP2019104937A (ja) * 2019-04-04 2019-06-27 イビデン株式会社 ヒアルロン酸及び／又はその塩の粉末
CN110423291B (zh) * 2019-09-06 2020-06-16 焦点生物医药有限公司 一种速溶透明质酸钠制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7811306L (sv) 1978-11-01 1980-05-02 Rothman Gunnvor Antikoagulationsmedel samt sett for dess framstellning
DE3482812D1 (de) 1983-10-11 1990-08-30 Fidia Spa Fraktionen von hyaluronsaeure mit pharmazeutischer aktivitaet, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
FR2584728B1 (fr) 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
IT1198449B (it) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
DK505588D0 (da) 1988-02-26 1988-09-09 Jesper Hamburger Middel og anvendelse af samme
IT1219942B (it) 1988-05-13 1990-05-24 Fidia Farmaceutici Esteri polisaccaridici
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
IT1247175B (it) 1991-04-19 1994-12-12 Fidia Spa Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
IT1254704B (it) * 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
IT1260148B (it) 1992-04-17 1996-03-28 Fidia Spa Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo
ITPD940054A1 (it) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
AU695207B2 (en) * 1995-03-28 1998-08-06 Fidia Farmaceutici S.P.A. Nanospheres comprising a biocompatible polysaccharide
US5833891A (en) * 1996-10-09 1998-11-10 The University Of Kansas Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
IT1287698B1 (it) 1996-08-29 1998-08-18 Fidia Advanced Biopolymers Srl Fili da sutura essenzialmente costituiti da derivati esterei dello acido ialuronico
DK0971961T3 (da) 1997-04-04 2003-03-24 Fidia Advanced Biopolymers Srl N-sulfaterede hyaluronsyreforbindelser, derivater deraf og en fremgangsmåde til deres fremstilling

Also Published As

Publication number Publication date
ITPD990071A1 (it) 2000-10-08
ES2194727T3 (es) 2003-12-01
EP1169387A1 (de) 2002-01-09
US7087745B1 (en) 2006-08-08
ATE234341T1 (de) 2003-03-15
CA2369284A1 (en) 2000-10-19
CA2369284C (en) 2010-01-12
JP2002541888A (ja) 2002-12-10
AU4912600A (en) 2000-11-14
EP1169387B1 (de) 2003-03-12
DE60001640T2 (de) 2004-03-25
AU765563B2 (en) 2003-09-25
WO2000061675A1 (en) 2000-10-19
IT1306644B1 (it) 2001-10-02

Similar Documents

Publication Publication Date Title
DE60001640D1 (de) Dreidimensionale struktur enthaltend hyaluronsäurederivat, hergestellt durch die technik von superkritischen antilösungsmitteln
PT1144459E (pt) Acidos hialuronicos reticulados e as suas utilizacoes em medicina
ATE212545T1 (de) Nanosphären mit einem biokompatiblen polysaccharid
BR0113663A (pt) Composições de pelìcula de pectina
NO995810D0 (no) Nye forbindelser
ATE208772T1 (de) Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung
NL300098I2 (nl) Thiofeensulfonamiden die bruikbaar zijn als carbo-anhydraseremmers.
SE0100901D0 (sv) New composition
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
HUP0300061A2 (hu) IL-18 inhibitorok alkalmazása
ATE345780T1 (de) Lyophilisierende zusammensetzung von wirkstoff- verkapselnder polymer-mizelle und verfahren zu ihrer herstellung
HUP0105103A2 (hu) Tumornekrózis faktor-antagonisták és alkalmazásuk endometriózisban
IT1305313B1 (it) 3,4 - diidro- 6- benzil-4-oxopirimidine sostituite e relativo processodi produzione e impiego nella terapia delle infezioni da hiv-1.
NO20050247L (no) Lavmolekylaert oversulfatert polysakkarid
DK0387821T3 (da) 2-Alkyl-4-arylmethylchinoliner, deres anvendelse og lægemidler fremstillet hermed
ATE325135T1 (de) 2-alkylierte cyclodextrinderivate : umkehrungsmittel von medikament-induzierter neuromuskulärer blockierung
SE9904581D0 (sv) A novel helicobacter pylori-binding substance and use thereof
DE69120287T2 (de) Aminosulfonylharnstoff-acat-inhibitoren
IT1306643B1 (it) Processo per la preparazione dei composti autoreticolati dell'acidoialuronico e dei suoi derivati ottenibili mediante la tecnica
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
PT1178787E (pt) Composicoes farmacologicas para administracao por via oral de floroglucinol e suas preparacoes
DE60008293D1 (de) Pharmazeutische zusammensetzung die einen no donor enthält und dessen therapeutische anwendung
SE0203313D0 (sv) Behållare med syrabarriär och användning därav
AU2001239180A1 (en) Immunomodulatory effective compositions, methods for the production thereof and their use
FR2811572B1 (fr) Utilisation de cyclodextrines polysulfatees pour le traitement de l'arthrose

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: FIDIA FARMACEUTICI S.P.A., ABANO TERME, PADUA/PADO

8364 No opposition during term of opposition